526445 — Indrayani Biotech Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹2.07bn
- IN₹2.89bn
- IN₹1.63bn
2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 6.79 | 15 | 127 |
Net Total Accounts Receivable | |||
Net Total Receivables | 78.5 | 154 | 323 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 96.2 | 189 | 775 |
Net Property, Plant And Equipment | 253 | 259 | 479 |
Net Goodwill | |||
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 401 | 514 | 1,560 |
Accounts Payable | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 118 | 195 | 719 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Minority Interest | |||
Total Liabilities | 203 | 272 | 1,009 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 197 | 242 | 551 |
Total Liabilities & Shareholders' Equity | 401 | 514 | 1,560 |
Total Common Shares Outstanding |